RHEONIS presented its innovative approach for biosourced to the members of the Biomolecules Commission of the IAR Cluster

A member of the IAR cluster since the beginning of 2019, RHEONIS was invited on October 3 to present its innovative approach as part of the cluster's Biomolecules Commission.

Vincent Billot-Ridet, CEO of RHEONIS, thus shared in front of the thirty participants the observation of RHEONIS on the implications of empirical practices in formulation and their limits for anticipating the industrialization of products. In particular, substitution approaches using biosourced ingredients are often penalized by the difficulties in adjusting the formulations to a target profile.

RHEONIS pleads for a better integration of modern techniques from applied research, which make it possible to develop "accelerated formulation" methods and therefore to save precious time for the substitution of ingredients and the development of innovative biosourced formulas.

https://www.iar-pole.com/evenements/commission-biomolecules-3-octobre-2019-2/